NCT00211679View on ClinicalTrials.gov

Intra-articularInjection of Botulinum Toxin Type

PHASE2UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

June 30, 2007

Conditions
ArthritisPain
Interventions
DRUG

Botulinum Toxin Type A

Trial Locations (1)

55417

RECRUITING

Minneapolis VAMC, Minneapolis

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

collaborator

Center for Veterans Research and Education

OTHER

lead

Minneapolis Veterans Affairs Medical Center

FED